Browse the latest research summaries in the field of urology for spinal cord injury patients and caregivers.
Showing 141-150 of 389 results
Spinal Cord Series and Cases, 2021 • May 13, 2021
This study investigated sexual dysfunction (SD) in Greek women with spinal cord injury (SCI), finding a 63.3% prevalence, which is generally consistent with international literature but somewhat lower...
KEY FINDING: The study revealed that 63.3% of the participants experienced sexual dysfunction.
Sex Disabil, 2021 • March 1, 2021
The study aimed to develop and validate a culturally appropriate instrument, the Sexual Performance Questionnaire (SPQ-SCI), to measure sexual performance among Iranian people with spinal cord injurie...
KEY FINDING: The developed 13-item Sexual Performance Questionnaire (SPQ-SCI) is a reliable and valid instrument for assessing sexual performance in Iranian PwSCI, with a Cronbach's alpha of 0.77 and an interclass correlation coefficient of 0.75.
Central European Journal of Urology, 2021 • October 28, 2021
This study investigated the use of gabapentin as an add-on therapy for patients with spinal cord injury who have neurogenic overactive detrusor that is unresponsive to combined anticholinergic and bet...
KEY FINDING: In 11 patients (40.17%), gabapentin add-on therapy led to decreased detrusor contractions, maximal detrusor pressure, and the number of incontinence episodes.
BJUI Compass, 2021 • January 1, 2021
This systematic review evaluates the cost-effectiveness of hydrophilic-coated versus uncoated catheters for individuals with spinal cord injury by analyzing existing economic evaluations. The review i...
KEY FINDING: Five studies found hydrophilic-coated catheters to be cost-effective compared to uncoated catheters.
Spinal Cord, 2023 • April 12, 2023
This study investigated sex differences in urological management during SCI rehabilitation, focusing on bladder storage medication and suprapubic catheter use. The results indicated that female-male d...
KEY FINDING: Cervical SCI and traumatic SCI were predictors of bladder storage medication use in both sexes.
Top Spinal Cord Inj Rehabil, 2022 • December 1, 2022
The study protocol describes a comparative effectiveness trial evaluating intravesical Lactobacillus rhamnosus GG (LGG) versus saline bladder wash (BW) for managing urinary symptoms in individuals wit...
KEY FINDING: The study will compare the effects of LGG and saline bladder wash on urinary symptoms, episodes of presumed UTIs, antibiotic use, days of lost activity, healthcare engagement, number of instillations, satisfaction, and safety.
J. Pers. Med., 2022 • December 1, 2022
This review highlights the current state of SCI research relating to sexual function, reproductive health, and the search for meaning. Multiple safe and effective treatments are available to address m...
KEY FINDING: SCI can impair multiple components involved in sexual function, including libido, achieving and maintaining an erection, ejaculation, and orgasm.
World Journal of Clinical Cases, 2023 • January 6, 2023
This article reviews the research progress of rehabilitation treatment and nursing care of patients with neurogenic bladder after spinal cord injury, in order to provide reference for the rehabilitati...
KEY FINDING: Existing treatments for neurogenic bladder, such as surgery and drugs, can negatively impact the patient's mental health to varying degrees.
Spinal Cord Series and Cases, 2023 • February 3, 2023
This internet-based survey examined the incidence and frequency of symptomatic urinary tract infections (sUTIs) in persons with spinal cord lesions (SCL) in Japan, focusing on different catheter types...
KEY FINDING: The incidence of sUTI was significantly higher in the ISC group (52.2%) compared to the IDC group (31.4%).
Top Spinal Cord Inj Rehabil, 2023 • January 1, 2023
This study explored the association between dipstick-determined bladder inflammation, presence of nitrite, and valid and reliable urinary symptoms among people with NLUTD using indwelling catheterizat...
KEY FINDING: No association was observed between clinically actionable (A), bladder (B1), and urine quality (B2) symptoms and positive dipstick results.